Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

Market Cap	524.99M -24.5%
Revenue (ttm)	346.26M +1.3%
Net Income	4.84M -82.7%
EPS	0.30 -82.6%
Shares Out	n/a
PE Ratio	108.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,781
Open	32.05
Previous Close	32.29
Day's Range	32.05 - 32.63
52-Week Range	25.60 - 46.34
Beta	0.57
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About NSE:BIOFILCHEM

Biofil Chemicals and Pharmaceuticals Limited engages in the manufacturing and trading of pharmaceutical products in India. It operates through Pharma and Chemical segments. The company offers basic drugs and chemicals, including sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrus fumerate, micro crystalline cellulose, and dicyclomine hydrochloride. It also provides ferrous sulphate in crystal, exsiccated, and granular form; microcrystalline cellulose powder; cellulos...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 24
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BIOFILCHEM

Financial Performance

In fiscal year 2026, NSE:BIOFILCHEM's revenue was 283.95 million, a decrease of -15.45% compared to the previous year's 335.82 million. Earnings were 27.86 million, an increase of 399.55%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 24, 2026

Data Sources Report a data error